Sciegen Pharmaceuticals Inc 2023-03-08 Health moderate FDA
Health · FDA · Recall #FDA-D-0354-2023
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen… Recall
Issued March 8, 2023 · Sciegen Pharmaceuticals Inc
In March 2023, Sciegen Pharmaceuticals Inc recalled the Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
What you should do
- 1 Stop using Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Sciegen Pharmaceuticals Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Sciegen Pharmaceuticals Inc
- Category
- Health
- Recall date
- March 8, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA and Puerto Rico
- Recall number
- FDA-D-0354-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Sciegen Pharmaceuticals Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.